Wendy S. Johnson Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Wendy S. Johnson.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Wendy S. Johnson. Wendy S. Johnson is a Director in AmpliPhi Biosciences Corp ($APHB) and a Interim Chief Operating Office in AmpliPhi Biosciences Corp ($APHB) and a See Remarks in AmpliPhi Biosciences Corp ($APHB) and a Director in EXAGEN INC. ($XGN).

Address: 800 EAST LEIGH STREET, SUITE 209 RICHMOND 23219 VA

Companies in which Wendy S. Johnson is an Insider

Armata Pharmaceuticals, Inc.

Trading Symbol: APHB
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Wendy S. Johnson: Director, Interim Chief Operating Office, See Remarks
Holdings: 1,000 shares
Current Value: $540
Latest Transaction: Sep 11 2017
$APHB Market Capitalization: $5.61M
$APHB Previous Close: $0.54

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

EXAGEN INC.

Trading Symbol: XGN
Industry: SERVICES-MEDICAL LABORATORIES [8071]
Position of Wendy S. Johnson: Director
Holdings: 0 shares
Latest Transaction: Oct 01 2020

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Latest Insider Trading Transactions of Wendy S. Johnson

Sentiment: All, APHB, XGN

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Oct 01 2020XGNEXAGEN INC.Johnson Wendy S.DirectorOption ExerciseA11.2515,000168,75015,000
Sep 11 2017APHBAmpliPhi Bioscienc ...Johnson Wendy S.DirectorOption ExerciseA0.9110,9009,91910,900
Oct 07 2015APHBAmpliPhi Bioscienc ...Johnson Wendy S.Interim Chief Opera ...BuyP4.431,0004,4271,0000 to 1,000
Sep 23 2015APHBAmpliPhi Bioscienc ...Johnson Wendy S.See RemarksOption ExerciseA6.3816,200103,35616,200
Sep 10 2015APHBAmpliPhi Bioscienc ...Johnson Wendy S.See RemarksOption ExerciseA7.4649,965372,73949,965

View all Wendy S. Johnson insider transactions.